Brief: Chordate Medical Holding Q1 Loss After Financial Items Widens To SEK 7.4 Mln

Chordate Medical Holding AB (publ)

27/05/2022 07:35

May 27 (Reuters) - Chordate Medical Holding publ AB
 CMHM.ST :
    * CHORDATE MEDICAL HOLDING (PUBL) INTERIM REPORT  JAN-MARCH
2022
    * Q1 NET TURNOVER WAS SEK 68,633 (101,626)
    * Q1 PROFIT/LOSS AFTER FINANCIAL ITEMS WAS SEK -7,379,154
(-5,799,097)
    * WE CONTINUE TO FOLLOW MARKETING PLAN FOR 2022
    * THIS APPLIES NATURALLY TO BOTH MIGRAINE AND RHINITIS
INDICATIONS, BUT WE WILL HAVE A STRONGER FOCUS ON MIGRAINE

Source text for Eikon:  ID:nBQN9Cy3bp 
Further company coverage:  CMHM.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))